Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | PLAU | P00749 | 1/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | CASP3 | P42574 | 1/20 | 0.51 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.51 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL682591 | 0.92 | L3MBTL1 (0.67) | L3MBTL1MAPTPLAUSRD5A2RAB9A | |
| SCHEMBL11510809 | 0.90 | LTA4H (0.58) | L3MBTL1MAPTPLAUSRD5A2RAB9A | |
| SCHEMBL6201900 | 0.90 | RAB9A (0.59) | L3MBTL1MAPTSRD5A2RAB9AMAPK1 | |
| SCHEMBL7199268 | 0.89 | MAPT (0.67) | L3MBTL1MAPTPLAUSRD5A2RAB9A | |
| SCHEMBL7167952 | 0.86 | SRD5A2 (0.62) | L3MBTL1MAPTSRD5A2RAB9AALDH1A1 | |
| SCHEMBL24800 | 0.85 | MAPT (0.73) | L3MBTL1MAPTPLAUSRD5A2RAB9A | |
| SCHEMBL10767038 | 0.85 | SRD5A2 (0.60) | L3MBTL1MAPTSRD5A2RAB9AMAPK1 | |
| SCHEMBL13052378 | 0.85 | MAPK1 (0.53) | L3MBTL1MAPTPLAUSRD5A2RAB9A | |
| SCHEMBL10767044 | 0.85 | MEN1 (0.60) | L3MBTL1MAPTPLAUSRD5A2RAB9A | |
| SCHEMBL8956299 | 0.85 | SRD5A2 (0.60) | L3MBTL1MAPTSRD5A2RAB9AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122054902-A | Metal halide perovskite film, preparation method thereof and photovoltaic device | 南京工业大学 | 2026-05-15 | — | — | CN | claimed |
| CN-115466196-B | Preparation method of atorvastatin calcium intermediate | 宿迁阿尔法科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-115466196-A | Preparation method of atorvastatin calcium intermediate | 宿迁阿尔法科技有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-115260051-A | Preparation process of atorvastatin calcium intermediate | 江苏阿尔法药业股份有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-102382006-A | Synthesis method of 2-[2-(4-fluorophenyl)-2-oxa-1-phenylethyl]-4-methyl-3-oxa-N-phenylpentanamide | LIANYUNGANG HONGYE CHEMICAL CO LTD | 2012-03-21 | — | — | CN | claimed |
| CN-122054902-A | Metal halide perovskite film, preparation method thereof and photovoltaic device | 南京工业大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-114230447-B | Continuous flow preparation method of 4' -fluoro-2-phenyl acetophenone | 河南豫辰药业股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-115572244-B | 2' -Aryl chalcone compound, preparation method and application thereof in pharmacy | 复旦大学 | 2024-04-30 | — | — | CN | disclosed |
| CN-115466196-B | Preparation method of atorvastatin calcium intermediate | 宿迁阿尔法科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-115466196-B | Preparation method of atorvastatin calcium intermediate | 宿迁阿尔法科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-115572244-A | 2' -aryl chalcone compound, preparation method and application thereof in pharmacy | 复旦大学 | 2023-01-06 | — | — | CN | disclosed |
| CN-115466196-A | Preparation method of atorvastatin calcium intermediate | 宿迁阿尔法科技有限公司 | 2022-12-13 | — | — | CN | disclosed |
| US-4898880-A | N-(heterocycle)alkyl)-1H-pyrazole-1-alkanamides as antiarrhythmic agents, compositions and use | STERLING DRUG INC. (US) | 1990-02-06 | — | — | US | disclosed |
| US-4897422-A | TREATMENT OF ASTHMA, RHEUMATIC DISEASES; ANTIARTHRITIC AGENTS, ANTIINFLAMMATORY AGENTS | ABBOTT LABORATORIES (US) | 1990-01-30 | — | — | US | disclosed |
| US-4870095-A | 1H-pyrazole-1-alkanamides, antiarrhythmic compositions and use | STERLING DRUG, INC. (US) | 1989-09-26 | — | — | US | disclosed |
| US-4829081-A | ATHEROSCLEROSIS, ANTICHOLESTEROL | SANDOZ PHARM. CORP. (US) | 1989-05-09 | — | — | US | disclosed |
| EP-0279281-A2 | Lipoxygenase inhibiting compounds | ABBOTT LABORATORIES (US) | 1988-08-24 | — | — | EP | disclosed |
| WO-1987002662-A2 | HETEROCYCLIC ANALOGS OF MEVALONOLACTONE AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICALS | SANDOZ AG (CH) | 1987-05-07 | — | — | WO | disclosed |
| EP-0221025-A1 | Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals | SANDOZ AG (CH) | 1987-05-06 | — | — | EP | disclosed |
| US-4613610-A | TREATING ATHEROSCLEROSIS AND HYPERLIPEMIA | SANDOZ PHARMACEUTICALS CORP. (US) | 1986-09-23 | — | — | US | disclosed |